MIR1290 is a microRNA implicated in various human tumors, functioning as an oncoMiR by regulating gene expression post-transcriptionally [PMC5604572]. It is transcribed from a gene on chromosome 1p36.13 and has been studied for its role in tumorigenesis, including melanoma [PMC8740132], [PMC5604572]. In melanoma, MIR1290 is upregulated in primary tissues and has been shown to inhibit autophagy by targeting BECN1, a key autophagic gene [PMC5604572]. The inhibition of MIR1290 leads to increased BECN1 expression and autophagy induction, suggesting a potential therapeutic strategy for melanoma treatment by downregulating MIR1290 to enhance autophagy [PMC5604572], [PMC9048552]. Additionally, MIR1290 has diagnostic potential as it differentiates pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors with high accuracy and may serve as an early diagnostic marker for necrotizing enterocolitis with high sensitivity and specificity [PMC9554633], [PMC9523100]. Furthermore, it is differentially expressed in exosomal miRNAs from various body fluids, indicating its potential as a circulating biomarker for diseases like colorectal adenoma and high-grade serous ovarian cancer [PMC8116025], [PMC8080718].
-- a g cac gu u a gagcguc c uuga ucaaaaa uucaga uuugga c ||||||| | |||| ||||||| |||||| |||||| cucguAG G GACU GGUUUUU AGGUuu aggcuu a aa - - --A -- u u
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0005880 |
Description | Homo sapiens hsa-miR-1290 mature miRNA |
Sequence | 53 - UGGAUUUUUGGAUCAGGGA - 71 |
Evidence |
experimental
Illumina [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|